Literature DB >> 9661006

Fluconazole resistance associated with drug efflux and increased transcription of a drug transporter gene, PDH1, in Candida glabrata.

H Miyazaki1, Y Miyazaki, A Geber, T Parkinson, C Hitchcock, D J Falconer, D J Ward, K Marsden, J E Bennett.   

Abstract

Sequential Candida glabrata isolates were obtained from the mouth of a patient infected with human immunodeficiency virus type 1 who was receiving high doses of fluconazole for oropharyngeal thrush. Fluconazole-susceptible colonies were replaced by resistant colonies that exhibited both increased fluconazole efflux and increased transcripts of a gene which codes for a protein with 72.5% identity to Pdr5p, an ABC multidrug transporter in Saccharomyces cerevisiae. The deduced protein had a molecular mass of 175 kDa and was composed of two homologous halves, each with six putative transmembrane domains and highly conserved sequences of ATP-binding domains. When the earliest and most azole-susceptible isolate of C. glabrata from this patient was exposed to fluconazole, increased transcripts of the PDR5 homolog appeared, linking azole exposure to regulation of this gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9661006      PMCID: PMC105668     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  41 in total

1.  Genotypic identification and characterization of species and strains within the genus Candida by using random amplified polymorphic DNA.

Authors:  P F Lehmann; D Lin; B A Lasker
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

Review 2.  Resistance of Candida species to fluconazole.

Authors:  J H Rex; M G Rinaldi; M A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

3.  Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals.

Authors:  R Prasad; P De Wergifosse; A Goffeau; E Balzi
Journal:  Curr Genet       Date:  1995-03       Impact factor: 3.886

4.  Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals.

Authors:  D J Sullivan; T J Westerneng; K A Haynes; D E Bennett; D C Coleman
Journal:  Microbiology       Date:  1995-07       Impact factor: 2.777

5.  Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.

Authors:  D Sanglard; K Kuchler; F Ischer; J L Pagani; M Monod; J Bille
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

6.  Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility.

Authors:  A Geber; C A Hitchcock; J E Swartz; F S Pullen; K E Marsden; K J Kwon-Chung; J E Bennett
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

7.  Altered P450 activity associated with direct selection for fungal azole resistance.

Authors:  T Joseph-Horne; D Hollomon; R S Loeffler; S L Kelly
Journal:  FEBS Lett       Date:  1995-10-30       Impact factor: 4.124

8.  bfr1+, a novel gene of Schizosaccharomyces pombe which confers brefeldin A resistance, is structurally related to the ATP-binding cassette superfamily.

Authors:  K Nagao; Y Taguchi; M Arioka; H Kadokura; A Takatsuki; K Yoda; M Yamasaki
Journal:  J Bacteriol       Date:  1995-03       Impact factor: 3.490

9.  Identification and characterization of SNQ2, a new multidrug ATP binding cassette transporter of the yeast plasma membrane.

Authors:  A Decottignies; L Lambert; P Catty; H Degand; E A Epping; W S Moye-Rowley; E Balzi; A Goffeau
Journal:  J Biol Chem       Date:  1995-07-28       Impact factor: 5.157

10.  Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata.

Authors:  T Parkinson; D J Falconer; C A Hitchcock
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

View more
  56 in total

1.  Phenotypic switching in Candida glabrata involves phase-specific regulation of the metallothionein gene MT-II and the newly discovered hemolysin gene HLP.

Authors:  S A Lachke; T Srikantha; L K Tsai; K Daniels; D R Soll
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole.

Authors:  Annemarie Borst; Maria T Raimer; David W Warnock; Christine J Morrison; Beth A Arthington-Skaggs
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

3.  Antifungal resistance of Candida glabrata vaginal isolates and development of a quantitative reverse transcription-PCR-based azole susceptibility assay.

Authors:  Scott E Gygax; John-Paul Vermitsky; Sean G Chadwick; Matthew J Self; Jessica A Zimmerman; Eli Mordechai; Martin E Adelson; Jason P Trama
Journal:  Antimicrob Agents Chemother       Date:  2008-06-30       Impact factor: 5.191

4.  Contributions of Aspergillus fumigatus ATP-binding cassette transporter proteins to drug resistance and virulence.

Authors:  Sanjoy Paul; Daniel Diekema; W Scott Moye-Rowley
Journal:  Eukaryot Cell       Date:  2013-10-11

5.  Relative Contribution of the ABC Transporters Cdr1, Pdh1, and Snq2 to Azole Resistance in Candida glabrata.

Authors:  Sarah G Whaley; Qing Zhang; Kelly E Caudle; P David Rogers
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

6.  In vitro and in vivo effects of 14alpha-demethylase (ERG11) depletion in Candida glabrata.

Authors:  H Nakayama; N Nakayama; M Arisawa; Y Aoki
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

7.  Conservation of a portion of the S. cerevisiae Ure2p prion domain that interacts with the full-length protein.

Authors:  Herman K Edskes; Reed B Wickner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

8.  Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor.

Authors:  John-Paul Vermitsky; Thomas D Edlind
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

9.  The Pathophysiology and Treatment of Candida Sepsis.

Authors:  Brad Spellberg; John E. Edwards
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

10.  Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence.

Authors:  Sélène Ferrari; Françoise Ischer; David Calabrese; Brunella Posteraro; Maurizio Sanguinetti; Giovanni Fadda; Bettina Rohde; Christopher Bauser; Oliver Bader; Dominique Sanglard
Journal:  PLoS Pathog       Date:  2009-01-16       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.